Compare COR & NOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | NOC |
|---|---|---|
| Founded | 2001 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5B | 80.9B |
| IPO Year | 2001 | 2002 |
| Metric | COR | NOC |
|---|---|---|
| Price | $324.06 | $694.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $395.23 | ★ $675.29 |
| AVG Volume (30 Days) | ★ 1.1M | 712.1K |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | 0.73% | ★ 1.31% |
| EPS Growth | ★ 5.71 | 2.61 |
| EPS | 2.87 | ★ 29.08 |
| Revenue | ★ $321,332,819,000.00 | $41,954,000,000.00 |
| Revenue This Year | $8.91 | $5.60 |
| Revenue Next Year | $6.84 | $6.04 |
| P/E Ratio | $114.49 | ★ $24.24 |
| Revenue Growth | ★ 9.31 | 2.24 |
| 52 Week Low | $265.59 | $450.13 |
| 52 Week High | $377.54 | $774.00 |
| Indicator | COR | NOC |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 40.36 |
| Support Level | $283.43 | $682.89 |
| Resistance Level | $353.18 | $715.61 |
| Average True Range (ATR) | 8.76 | 15.80 |
| MACD | -4.04 | -7.85 |
| Stochastic Oscillator | 10.14 | 8.13 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.